Acetyl Hexapeptide-3 (Argireline) vs Tripeptide-29
SNARE complex inhibitor that reduces expression wrinkles through topical neuromuscular modulation — the 'Botox in a bottle' peptide.
The minimal collagen-mimetic tripeptide (Gly-Pro-Hyp) that stimulates fibroblast collagen synthesis and resists photoaging.
Written by Michael Carroll — Owner, Director of Research · Reviewed by the Peptide Initiative Research Team · Editorial standards
Quick comparison
Dose range
Acetyl Hexapeptide-3 (Argireline)
5–10 %
Tripeptide-29
1000–2500 mg/day
Frequency
Acetyl Hexapeptide-3 (Argireline)
Once daily
Tripeptide-29
Once daily
Administration
Acetyl Hexapeptide-3 (Argireline)
Topical
Tripeptide-29
Topical
Cycle length
Acetyl Hexapeptide-3 (Argireline)
Ongoing/indefinite
Tripeptide-29
Ongoing/indefinite
Onset speed
Acetyl Hexapeptide-3 (Argireline)
Moderate (1-2 weeks)
Tripeptide-29
Moderate (1-2 weeks)
Evidence level
Acetyl Hexapeptide-3 (Argireline)
Limited human trials
Tripeptide-29
Limited human trials
Benefit ratings
Expression Wrinkle Reduction
Non-Invasive Treatment
Safety Profile
Collagen Synthesis
Anti-Photoaging
Skin Hydration
Compound specifications
Acetyl Hexapeptide-3 (Argireline)
Molecular formula
C35H62N14O11S
Molecular weight
887.0 Da
Half-life
Topical stability dependent on formulation; methionine residue susceptible to oxidation; stable at pH 5.5-7.7
Bioavailability
Limited skin penetration (0.22-0.54%); primarily acts at stratum corneum and superficial epidermis; O/W emulsions enhance delivery
CAS number
616204-22-9
Tripeptide-29
Molecular formula
C12H19N3O5
Molecular weight
285.3 Da
Half-life
Oral: rapidly metabolized to Pro-Hyp; accumulates in skin tissue over hours; topical: sustained local activity
Bioavailability
4.4% absolute oral bioavailability; transporter-mediated intestinal absorption; preferential skin tissue accumulation
CAS number
2239-67-0
Dosing compared
Acetyl Hexapeptide-3 (Argireline)
Topical
5-10% concentration (cream or serum)
Twice daily (morning and evening) · Minimum 28-30 days; ongoing use to maintain effect
Used as a leave-on skin cream or serum. In studies, a 10% formula applied twice a day around the eyes reduced wrinkle depth by about 17% after 15 days and up to 27-30% after 30 days. It works on the skin surface only and is not injected. [1][2]
Tripeptide-29
Oral
1,000-2,500 mg/day of Gly-Pro-Hyp-rich collagen tripeptide
Once daily · 8-12 weeks for measurable skin changes
Human trials of low-molecular-weight collagen peptide used 1,000 mg/day for 12 weeks, improving skin hydration, elasticity, and wrinkling [6]; higher-end practice extends to ~2,500 mg/day [6].
Topical
0.05-0.1% (roughly 500-1,000 ppm) in a leave-on serum or cream
Once or twice daily · Ongoing cosmetic use
Typical cosmetic leave-on use level for collagen-derived tripeptides; applied to clean skin as part of a daily routine [1].
Best suited for
Acetyl Hexapeptide-3 (Argireline)
Individuals seeking non-invasive reduction of expression lines and dynamic wrinkles
Acetyl Hexapeptide-3 (Argireline) is particularly well-suited for individuals focused on individuals seeking non-invasive reduction of expression lines and dynamic wrinkles. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Those with needle phobia who want botulinum toxin-like effects without injections
Acetyl Hexapeptide-3 (Argireline) is particularly well-suited for individuals focused on those with needle phobia who want botulinum toxin-like effects without injections. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
People targeting crow's feet, forehead lines, and glabellar creases
Acetyl Hexapeptide-3 (Argireline) is particularly well-suited for individuals focused on people targeting crow's feet, forehead lines, and glabellar creases. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Individuals looking for preventive anti-wrinkle treatment to slow expression line formation
Acetyl Hexapeptide-3 (Argireline) is particularly well-suited for individuals focused on individuals looking for preventive anti-wrinkle treatment to slow expression line formation. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Tripeptide-29
Individuals seeking evidence-based collagen supplementation for skin health
Tripeptide-29 is particularly well-suited for individuals focused on individuals seeking evidence-based collagen supplementation for skin health. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Those with photoaged skin from chronic sun exposure
Tripeptide-29 is particularly well-suited for individuals focused on those with photoaged skin from chronic sun exposure. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
People wanting to support skin hydration and elasticity from both oral and topical routes
Tripeptide-29 is particularly well-suited for individuals focused on people wanting to support skin hydration and elasticity from both oral and topical routes. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Users looking for a collagen-mimetic peptide with clinical trial data supporting efficacy
Tripeptide-29 is particularly well-suited for individuals focused on users looking for a collagen-mimetic peptide with clinical trial data supporting efficacy. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Side effects
Acetyl Hexapeptide-3 (Argireline)
Common
- Mild Skin Irritation
- Transient Redness
- Slight Dryness
- Stinging on Compromised Skin
Uncommon
- Contact Dermatitis
Serious
- Allergic Contact Dermatitis
Tripeptide-29
Common
- Mild Gastrointestinal Adjustment
- Aftertaste (oral)
- Mild Skin Warmth (topical)
- Initial Skin Purging
Uncommon
- Allergic Sensitivity
Serious
- Anaphylaxis (theoretical)
- Limited Bioavailability and Potential Immunogenicity
Safety & evidence
Acetyl Hexapeptide-3 (Argireline)
Evidence level
Limited human trials
FDA status
Research compound
Safety overview
Acetyl Hexapeptide-3 demonstrates an excellent safety profile for topical cosmetic use with no serious adverse events reported in clinical studies. At the 10% concentrations used in cosmetic formulations, systemic absorption is minimal and no neurotoxicity has been observed despite its mechanism of action on the neuromuscular junction. The peptide shows a safety margin of approximately 100-fold compared to toxic reference compounds. Primary concerns are limited to local skin irritation in sensitive individuals, such as mild erythema, transient stinging, or contact dermatitis in those with peptide hypersensitivity.
Contraindications
- Known hypersensitivity to acetyl hexapeptide-3 or formulation components
- Active skin infections or open wounds at the application site
- No known systemic contraindications at cosmetic concentrations
- Use with caution in individuals with neuromuscular disorders (theoretical concern)
Tripeptide-29
Evidence level
Limited human trials
FDA status
Research compound
Safety overview
Tripeptide-29 (Gly-Pro-Hyp, glycyl-prolyl-hydroxyproline) is a naturally occurring collagen-derived tripeptide with an excellent cosmetic safety profile. This is the fundamental repeat unit of collagen protein, making it highly biocompatible. Both oral and topical forms demonstrate minimal adverse effects in clinical trials. No serious adverse events have been reported in published clinical studies spanning over 15 years. The tripeptide is generally recognized as safe (GRAS) for both topical and oral use by regulatory authorities. Individual responses are generally benign and limited to mild gastrointestinal adjustment with oral supplementation or transient dermal warmth with topical application. The primary safety consideration is allergenicity in individuals with gelatin or collagen allergies, which is rare but requires awareness. Molecular weight (285.3 Da) ensures limited systemic absorption when applied topically.
Contraindications
- Known allergy to collagen, gelatin, or animal-derived protein products
- Active skin infections or dermatitis at the topical application site
- Hypersensitivity to hydroxyproline-containing peptides
- Concurrent use with products at extreme pH that may hydrolyze the peptide
Which is right for you?
Choose Acetyl Hexapeptide-3 (Argireline) if...
- Individuals seeking non-invasive reduction of expression lines and dynamic wrinkles
- Those with needle phobia who want botulinum toxin-like effects without injections
- People targeting crow's feet, forehead lines, and glabellar creases
- Individuals looking for preventive anti-wrinkle treatment to slow expression line formation
Choose Tripeptide-29 if...
- Individuals seeking evidence-based collagen supplementation for skin health
- Those with photoaged skin from chronic sun exposure
- People wanting to support skin hydration and elasticity from both oral and topical routes
- Users looking for a collagen-mimetic peptide with clinical trial data supporting efficacy